X4 PHARMACEUTICALS, INC (XFOR) Operating cash flow 2016–2025
X4 PHARMACEUTICALS, INC (XFOR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$85.6MFY2025 · since FY2016: -$21.6M → -$85.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$85.6M | +34.6% |
| FY2024 | -$130.9M | -35.6% |
| FY2023 | -$96.5M | -25.2% |
| FY2022 | -$77.1M | -8.7% |
| FY2021 | -$70.9M | -20.5% |
| FY2020 | -$58.8M | -22.4% |
| FY2019 | -$48.1M | -89.0% |
| FY2018 | -$25.4M | -19.3% |
| FY2017 | -$21.3M | +1.5% |
| FY2016 | -$21.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice